Titre : Erreurs innées du métabolisme lipidique

Erreurs innées du métabolisme lipidique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Subcutaneous Fat
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Erreurs innées du métabolisme lipidique : Questions médicales les plus fréquentes", "headline": "Erreurs innées du métabolisme lipidique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Erreurs innées du métabolisme lipidique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme lipidique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Erreurs innées du métabolisme", "url": "https://questionsmedicales.fr/mesh/D008661", "about": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme", "code": { "@type": "MedicalCode", "code": "D008661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Barth", "alternateName": "Barth Syndrome", "url": "https://questionsmedicales.fr/mesh/D056889", "about": { "@type": "MedicalCondition", "name": "Syndrome de Barth", "code": { "@type": "MedicalCode", "code": "D056889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.224" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipidémie familiale mixte", "alternateName": "Hyperlipidemia, Familial Combined", "url": "https://questionsmedicales.fr/mesh/D006950", "about": { "@type": "MedicalCondition", "name": "Hyperlipidémie familiale mixte", "code": { "@type": "MedicalCode", "code": "D006950", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.450" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type I", "alternateName": "Hyperlipoproteinemia Type I", "url": "https://questionsmedicales.fr/mesh/D008072", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type I", "code": { "@type": "MedicalCode", "code": "D008072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.465" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type II", "alternateName": "Hyperlipoproteinemia Type II", "url": "https://questionsmedicales.fr/mesh/D006938", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type II", "code": { "@type": "MedicalCode", "code": "D006938", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.481" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypercholestérolémie familiale homozygote", "alternateName": "Homozygous Familial Hypercholesterolemia", "url": "https://questionsmedicales.fr/mesh/D000090542", "about": { "@type": "MedicalCondition", "name": "Hypercholestérolémie familiale homozygote", "code": { "@type": "MedicalCode", "code": "D000090542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.481.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type III", "alternateName": "Hyperlipoproteinemia Type III", "url": "https://questionsmedicales.fr/mesh/D006952", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type III", "code": { "@type": "MedicalCode", "code": "D006952", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.483" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type IV", "alternateName": "Hyperlipoproteinemia Type IV", "url": "https://questionsmedicales.fr/mesh/D006953", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type IV", "code": { "@type": "MedicalCode", "code": "D006953", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.487" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type V", "alternateName": "Hyperlipoproteinemia Type V", "url": "https://questionsmedicales.fr/mesh/D006954", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type V", "code": { "@type": "MedicalCode", "code": "D006954", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.493" } } }, { "@type": "MedicalWebPage", "name": "Hypolipoprotéinémies", "alternateName": "Hypolipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D007009", "about": { "@type": "MedicalCondition", "name": "Hypolipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D007009", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypoalphalipoprotéinémies", "alternateName": "Hypoalphalipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D052456", "about": { "@type": "MedicalCondition", "name": "Hypoalphalipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D052456", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "alternateName": "Lecithin Cholesterol Acyltransferase Deficiency", "url": "https://questionsmedicales.fr/mesh/D007863", "about": { "@type": "MedicalCondition", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "code": { "@type": "MedicalCode", "code": "D007863", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.500" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Tangier", "alternateName": "Tangier Disease", "url": "https://questionsmedicales.fr/mesh/D013631", "about": { "@type": "MedicalCondition", "name": "Maladie de Tangier", "code": { "@type": "MedicalCode", "code": "D013631", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "alternateName": "Lecithin Cholesterol Acyltransferase Deficiency", "url": "https://questionsmedicales.fr/mesh/D007863", "about": { "@type": "MedicalCondition", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "code": { "@type": "MedicalCode", "code": "D007863", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.500" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Tangier", "alternateName": "Tangier Disease", "url": "https://questionsmedicales.fr/mesh/D013631", "about": { "@type": "MedicalCondition", "name": "Maladie de Tangier", "code": { "@type": "MedicalCode", "code": "D013631", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.750" } } }, { "@type": "MedicalWebPage", "name": "Hypobêtalipoprotéinémies", "alternateName": "Hypobetalipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D006995", "about": { "@type": "MedicalCondition", "name": "Hypobêtalipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D006995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Abêtalipoprotéinémie", "alternateName": "Abetalipoproteinemia", "url": "https://questionsmedicales.fr/mesh/D000012", "about": { "@type": "MedicalCondition", "name": "Abêtalipoprotéinémie", "code": { "@type": "MedicalCode", "code": "D000012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Abêtalipoprotéinémie", "alternateName": "Abetalipoproteinemia", "url": "https://questionsmedicales.fr/mesh/D000012", "about": { "@type": "MedicalCondition", "name": "Abêtalipoprotéinémie", "code": { "@type": "MedicalCode", "code": "D000012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Lipidoses", "alternateName": "Lipidoses", "url": "https://questionsmedicales.fr/mesh/D008064", "about": { "@type": "MedicalCondition", "name": "Lipidoses", "code": { "@type": "MedicalCode", "code": "D008064", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Céroïdes-lipofuscinoses neuronales", "alternateName": "Neuronal Ceroid-Lipofuscinoses", "url": "https://questionsmedicales.fr/mesh/D009472", "about": { "@type": "MedicalCondition", "name": "Céroïdes-lipofuscinoses neuronales", "code": { "@type": "MedicalCode", "code": "D009472", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641.509" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Sjögren-Larsson", "alternateName": "Sjogren-Larsson Syndrome", "url": "https://questionsmedicales.fr/mesh/D016111", "about": { "@type": "MedicalCondition", "name": "Syndrome de Sjögren-Larsson", "code": { "@type": "MedicalCode", "code": "D016111", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641.723" } } } ] }, { "@type": "MedicalWebPage", "name": "Xanthomatose cérébrotendineuse", "alternateName": "Xanthomatosis, Cerebrotendinous", "url": "https://questionsmedicales.fr/mesh/D019294", "about": { "@type": "MedicalCondition", "name": "Xanthomatose cérébrotendineuse", "code": { "@type": "MedicalCode", "code": "D019294", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.925" } } } ], "about": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme lipidique", "alternateName": "Lipid Metabolism, Inborn Errors", "code": { "@type": "MedicalCode", "code": "D008052", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carlos R Ferreira", "url": "https://questionsmedicales.fr/author/Carlos%20R%20Ferreira", "affiliation": { "@type": "Organization", "name": "Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Rare Disease Institute, Children's National Health System, Washington, DC, United States." } }, { "@type": "Person", "name": "Clara D M van Karnebeek", "url": "https://questionsmedicales.fr/author/Clara%20D%20M%20van%20Karnebeek", "affiliation": { "@type": "Organization", "name": "Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. Electronic address: c.d.vankarnebeek@amstedarmumc.nl." } }, { "@type": "Person", "name": "Jerry Vockley", "url": "https://questionsmedicales.fr/author/Jerry%20Vockley", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, University of Pittsburgh School of Medicine, Department of Human Genetics, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA." } }, { "@type": "Person", "name": "Andrea L Gropman", "url": "https://questionsmedicales.fr/author/Andrea%20L%20Gropman", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Children's National, Washington, DC 20010, USA." } }, { "@type": "Person", "name": "Sumreena Mansoor", "url": "https://questionsmedicales.fr/author/Sumreena%20Mansoor", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Shifa College of Medicine, Shifa Tameer-e-millat university, H-8/4, Islamabad, Pakistan. dr.sumreena@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Infrapatellar fat pad size and subcutaneous fat in knee osteoarthritis radiographic progression: data from the osteoarthritis initiative.", "datePublished": "2024-07-30", "url": "https://questionsmedicales.fr/article/39080699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13075-024-03367-w" } }, { "@type": "ScholarlyArticle", "name": "Relationships of rapid eating with visceral and subcutaneous fat mass and plasma adiponectin concentration.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37460653", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-38623-7" } }, { "@type": "ScholarlyArticle", "name": "The Use of Autologous Subcutaneous Fat Tissue to Embolize an Infected Iliac Artery Pseudoaneurysm.", "datePublished": "2023-07-30", "url": "https://questionsmedicales.fr/article/37518891", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/15385744231192880" } }, { "@type": "ScholarlyArticle", "name": "A comparative study of full-thickness skin grafting with and without subcutaneous fat preservation.", "datePublished": "2022-11-03", "url": "https://questionsmedicales.fr/article/36330586", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/iwj.13975" } }, { "@type": "ScholarlyArticle", "name": "Metabolic aspects of surgical subcutaneous fat removal: An umbrella review and implications for future research.", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36200436", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17305/bjbms.2022.8175" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies métaboliques et nutritionnelles", "item": "https://questionsmedicales.fr/mesh/D009750" }, { "@type": "ListItem", "position": 3, "name": "Maladies métaboliques", "item": "https://questionsmedicales.fr/mesh/D008659" }, { "@type": "ListItem", "position": 4, "name": "Erreurs innées du métabolisme", "item": "https://questionsmedicales.fr/mesh/D008661" }, { "@type": "ListItem", "position": 5, "name": "Erreurs innées du métabolisme lipidique", "item": "https://questionsmedicales.fr/mesh/D008052" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Erreurs innées du métabolisme lipidique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Erreurs innées du métabolisme lipidique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Erreurs innées du métabolisme lipidique", "description": "Comment diagnostique-t-on une erreur métabolique lipidique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nQuelle est l'importance de l'histoire familiale ?\nPeut-on utiliser l'imagerie pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Erreurs innées du métabolisme lipidique", "description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon le type d'erreur ?\nY a-t-il des signes cutanés associés ?\nLes symptômes apparaissent-ils à la naissance ?\nLes troubles mentaux sont-ils possibles ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Erreurs innées du métabolisme lipidique", "description": "Peut-on prévenir ces erreurs ?\nLe conseil génétique est-il utile ?\nLes vaccinations sont-elles importantes ?\nLes tests prénataux sont-ils recommandés ?\nL'éducation des parents est-elle cruciale ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Erreurs innées du métabolisme lipidique", "description": "Quels traitements sont disponibles ?\nLa diététique joue-t-elle un rôle ?\nDes médicaments sont-ils utilisés ?\nLa thérapie génique est-elle une option ?\nLes greffes d'organes sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Erreurs innées du métabolisme lipidique", "description": "Quelles complications peuvent survenir ?\nLes erreurs lipidique peuvent-elles être mortelles ?\nY a-t-il des risques de cancer ?\nLes troubles psychologiques sont-ils fréquents ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Erreurs innées du métabolisme lipidique", "description": "Quels sont les facteurs de risque génétiques ?\nL'origine ethnique influence-t-elle le risque ?\nL'alimentation joue-t-elle un rôle ?\nLes infections peuvent-elles aggraver la condition ?\nLe sexe influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Subcutaneous+Fat&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une erreur métabolique lipidique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des analyses génétiques et des biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage néonatal, des dosages enzymatiques et des analyses d'urine sont courants." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques orientent le diagnostic et peuvent indiquer le type d'erreur." } }, { "@type": "Question", "name": "Quelle est l'importance de l'histoire familiale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'histoire familiale aide à identifier les risques génétiques et à orienter les tests." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer les organes affectés, mais n'est pas spécifique." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs abdominales, troubles neurologiques et retard de croissance." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'erreur ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque type d'erreur lipidique présente des symptômes spécifiques et variés." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent provoquer des dépôts lipidiques visibles sur la peau." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils à la naissance ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains symptômes peuvent apparaître dès la naissance, d'autres se développent plus tard." } }, { "@type": "Question", "name": "Les troubles mentaux sont-ils possibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs et comportementaux peuvent survenir dans certaines erreurs." } }, { "@type": "Question", "name": "Peut-on prévenir ces erreurs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est limitée, mais le dépistage néonatal peut aider à identifier les cas précoces." } }, { "@type": "Question", "name": "Le conseil génétique est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le conseil génétique aide les familles à comprendre les risques et les options de dépistage." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas les erreurs métaboliques, mais protègent contre d'autres maladies." } }, { "@type": "Question", "name": "Les tests prénataux sont-ils recommandés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des tests prénataux peuvent être proposés pour détecter certaines erreurs génétiques." } }, { "@type": "Question", "name": "L'éducation des parents est-elle cruciale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les parents sur les signes et symptômes peut aider à une détection précoce." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des régimes alimentaires spécifiques, des suppléments et des médicaments." } }, { "@type": "Question", "name": "La diététique joue-t-elle un rôle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime adapté est crucial pour gérer les niveaux de lipides et prévenir les complications." } }, { "@type": "Question", "name": "Des médicaments sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour réduire les niveaux de lipides ou traiter les symptômes." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour certaines erreurs, mais n'est pas encore courante." } }, { "@type": "Question", "name": "Les greffes d'organes sont-elles nécessaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, des greffes peuvent être envisagées pour traiter des dommages organiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies hépatiques, des troubles neurologiques et des problèmes cardiaques." } }, { "@type": "Question", "name": "Les erreurs lipidique peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent entraîner des complications graves pouvant être fatales sans traitement." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent augmenter le risque de développer certains types de cancer." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques peuvent survenir en raison de l'impact des symptômes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes sans traitement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux d'erreurs métaboliques augmentent le risque de transmission." } }, { "@type": "Question", "name": "L'origine ethnique influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines erreurs sont plus fréquentes dans des populations spécifiques en raison de la génétique." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée peut exacerber les symptômes chez les individus prédisposés." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la condition ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent déclencher ou aggraver les symptômes des erreurs métaboliques." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs métaboliques peuvent avoir une prévalence différente selon le sexe." } } ] } ] }

Sous-catégories

18 au total
└─

Syndrome de Barth

Barth Syndrome D056889 - C18.452.648.398.224
└─

Hyperlipidémie familiale mixte

Hyperlipidemia, Familial Combined D006950 - C18.452.648.398.450
└─

Hyperlipoprotéinémie de type I

Hyperlipoproteinemia Type I D008072 - C18.452.648.398.465
└─

Hyperlipoprotéinémie de type II

Hyperlipoproteinemia Type II D006938 - C18.452.648.398.481
└─

Hyperlipoprotéinémie de type III

Hyperlipoproteinemia Type III D006952 - C18.452.648.398.483
└─

Hyperlipoprotéinémie de type IV

Hyperlipoproteinemia Type IV D006953 - C18.452.648.398.487
└─

Hyperlipoprotéinémie de type V

Hyperlipoproteinemia Type V D006954 - C18.452.648.398.493
└─

Hypolipoprotéinémies

Hypolipoproteinemias D007009 - C18.452.648.398.500
└─

Lipidoses

Lipidoses D008064 - C18.452.648.398.641
└─

Xanthomatose cérébrotendineuse

Xanthomatosis, Cerebrotendinous D019294 - C18.452.648.398.925
└─└─

Hypercholestérolémie familiale homozygote

Homozygous Familial Hypercholesterolemia D000090542 - C18.452.648.398.481.500
└─└─

Hypoalphalipoprotéinémies

Hypoalphalipoproteinemias D052456 - C18.452.648.398.500.330
└─└─

Hypobêtalipoprotéinémies

Hypobetalipoproteinemias D006995 - C18.452.648.398.500.440
└─└─

Céroïdes-lipofuscinoses neuronales

Neuronal Ceroid-Lipofuscinoses D009472 - C18.452.648.398.641.509
└─└─

Syndrome de Sjögren-Larsson

Sjogren-Larsson Syndrome D016111 - C18.452.648.398.641.723
└─└─└─

Déficit en lécithine-cholestérol-acyl-transférase

Lecithin Cholesterol Acyltransferase Deficiency D007863 - C18.452.648.398.500.330.500
└─└─└─

Maladie de Tangier

Tangier Disease D013631 - C18.452.648.398.500.330.750
└─└─└─

Abêtalipoprotéinémie

Abetalipoproteinemia D000012 - C18.452.648.398.500.440.500

Sources (7511 au total)

Infrapatellar fat pad size and subcutaneous fat in knee osteoarthritis radiographic progression: data from the osteoarthritis initiative.

Adipose tissue has been associated with knee osteoarthritis (KOA) pathogenesis, but the longitudinal changes in adipose tissue with KOA progression have not been carefully evaluated. This study aimed ... This case-control study used data from the Osteoarthritis Initiative (OAI) and included 315 cases (all the right knees with a minimum of Kellgren-Lawrence score (KL) of 0 and an increase of ≥ 1 KL fro... 24-month changes of IPFP CSA (ΔIPFP CSA) and SCATthigh (ΔSCATthigh) were significantly greater in cases compared to controls, whereas Δ BMI and Δ abdominal circumference were similar in both groups du... Subjects with radiographic progression of KOA, had significant increases in IPFP CSA and subcutaneous adipose tissue while BMI and abdominal circumference remained stable. Additional studies are neede...

A low subcutaneous fat mass is a risk factor for the development of inguinal hernia after radical prostatectomy.

Inguinal hernia (IH) after radical prostatectomy (RP) is a complication that impairs quality of life; however, the factors contributing to IH after RP remain unclear. Therefore, we herein attempted to... We reviewed 622 patients who underwent laparoscopic or robot-assisted laparoscopic RP at our hospital between December 2011 and April 2020. The total fat area and visceral fat area were calculated at ... IH developed in 88 patients (16.7%). Fifty-seven of these patients underwent hernia repair at our hospital, and 56 (98.2%) had indirect hernias. A multivariate analysis identified SFA (odds ratios: 0.... Subcutaneous fat was associated with the development of IH, particularly indirect IH, after laparoscopic or robot-assisted laparoscopic RP. An indirect IH prevention technique needs to be considered, ...

Subcutaneous Fat Abundance and Density Are Associated with an Enhanced Response to Immunotherapy in Metastatic Melanoma: A Retrospective Cohort Study.

Despite the impressive efficacy of immune checkpoint inhibitors (ICIs) in the treatment of metastatic melanoma, not all patients respond to therapy. In addition, ICI harbors the risk for serious adver... In the current work, we analyze adipose tissue abundance and density, as well as muscle mass via computed tomography scans in a retrospective cohort of 100 patients with non-resectable stage III/IV me... Low SATGI was associated with prolonged progression-free survival (PFS) in univariate and multivariate analyses (hazard ratio 2.56 [95% CI 1.18-5.55], P = .02), as well as an enhanced objective respon... We identify SATGI as a biomarker predicting treatment response to ICI without increased risk for severe AEs in melanoma....